Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2023	$ 11	$ 4,123	$ (6,212)	$ (2,078)
Balance, shares at Dec. 31, 2023	10,562,640
Fair value of vested restricted stock units		5		5
Fair value of vested restricted stock units, shares
Net loss			(1,623)	(1,623)
Issuance of common shares upon the closing of the initial public offering, net of offering costs	$ 2	4,650		4,652
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares	1,550,000
Issuance of common shares upon conversion of convertible notes payable and accrued interest		884		884
Issuance of common shares upon conversion of convertible notes payable and accrued interes, shares	368,371
Issuance of common shares upon conversion of accounts payable		1,456		1,456
Issuance of common shares upon conversion of accounts payable, shares	364,110
Issuance of common shares upon conversion of amounts due to related parties		7		7
Issuance of common shares upon conversion of amounts due to related parties, shares	1,664
Fair value of warrants issued in connection with convertible notes payable		29		29
Balance at Sep. 30, 2024	$ 13	11,154	(7,835)	3,332
Balance, shares at Sep. 30, 2024	12,846,785
Balance at Dec. 31, 2023	$ 11	4,123	(6,212)	(2,078)
Balance, shares at Dec. 31, 2023	10,562,640
Balance at Dec. 31, 2024	$ 14	13,577	(8,815)	4,776
Balance, shares at Dec. 31, 2024	13,736,597
Balance at Jun. 30, 2024	$ 11	4,123	(6,788)	(2,654)
Balance, shares at Jun. 30, 2024	10,562,640
Fair value of vested restricted stock units		5		5
Fair value of vested restricted stock units, shares
Net loss			(1,047)	(1,047)
Issuance of common shares upon the closing of the initial public offering, net of offering costs	$ 2	4,650		4,652
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares	1,550,000
Issuance of common shares upon conversion of convertible notes payable and accrued interest		884		884
Issuance of common shares upon conversion of convertible notes payable and accrued interes, shares	368,371
Issuance of common shares upon conversion of accounts payable		1,456		1,456
Issuance of common shares upon conversion of accounts payable, shares	364,110
Issuance of common shares upon conversion of amounts due to related parties		7		7
Issuance of common shares upon conversion of amounts due to related parties, shares	1,664
Fair value of warrants issued in connection with convertible notes payable		29		29
Balance at Sep. 30, 2024	$ 13	11,154	(7,835)	3,332
Balance, shares at Sep. 30, 2024	12,846,785
Balance at Dec. 31, 2024	$ 14	13,577	(8,815)	4,776
Balance, shares at Dec. 31, 2024	13,736,597
Common shares issued for cash through equity line of credit, net of expenses	$ 4	3,201		3,205
Common shares issued for cash through equity line of credit, net of expenses, shares	3,510,000
Fair value of vested restricted stock units		223		223
Fair value of vested restricted stock units, shares	144,707
Issuance of common shares through cashless exercise of stock warrants
Issuance of common shares through cashless exercise of stock warrants, shares	11,402
Net loss			(4,082)	(4,082)
Fair value of common shares issued for deferred offering costs		327		327
Fair value of common shares issued for deferred offering costs, shares	384,459
Proceeds from the sale of common shares and pre-funded warrants, net of offering costs	$ 2	3,056		3,058
Proceeds from the sale of common shares and pre-funded warrants, net of offering costs, shares	2,500,000
Issuance of common shares recorded as a vendor advance	$ 1	156		157
Issuance of common shares recorded as a vendor advance, shares	534,188
Balance at Sep. 30, 2025	$ 21	20,540	(12,897)	7,664
Balance, shares at Sep. 30, 2025	20,821,353
Balance at Jun. 30, 2025	$ 18	17,478	(11,499)	5,997
Balance, shares at Jun. 30, 2025	17,743,765
Common shares issued for cash through equity line of credit, net of expenses	$ 3	2,992		2,995
Common shares issued for cash through equity line of credit, net of expenses, shares	3,000,000
Fair value of vested restricted stock units		70		70
Fair value of vested restricted stock units, shares	66,186
Issuance of common shares through cashless exercise of stock warrants
Issuance of common shares through cashless exercise of stock warrants, shares	11,402
Net loss			(1,398)	(1,398)
Balance at Sep. 30, 2025	$ 21	$ 20,540	$ (12,897)	$ 7,664
Balance, shares at Sep. 30, 2025	20,821,353